Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient

Int J Antimicrob Agents. 2016 Aug;48(2):225-7. doi: 10.1016/j.ijantimicag.2016.06.002. Epub 2016 Jun 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacology
  • Azabicyclo Compounds / administration & dosage*
  • Bacteremia / drug therapy*
  • Bacteremia / microbiology
  • Bacterial Proteins / metabolism*
  • Ceftazidime / administration & dosage*
  • Drug Combinations
  • Fatal Outcome
  • Female
  • Humans
  • Infusions, Intravenous / methods
  • Kidney Transplantation
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / enzymology*
  • Klebsiella pneumoniae / isolation & purification
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pancreas Transplantation
  • Transplant Recipients
  • Treatment Outcome
  • United States
  • beta-Lactamase Inhibitors / administration & dosage*
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Azabicyclo Compounds
  • Bacterial Proteins
  • Drug Combinations
  • avibactam, ceftazidime drug combination
  • beta-Lactamase Inhibitors
  • Ceftazidime
  • beta-Lactamases
  • beta-lactamase KPC-3, Klebsiella pneumoniae